Difficulty: Medium
Average Score: 84%
Practice
What screening method should be used for a patient with a history of BCG vaccine?
Correct answer
D
Rationale
In the context of screening a patient with a history of BCG vaccine for TB infection, the correct answer is option D) Blood test. The rationale behind this is that individuals who have received the BCG vaccine can develop a positive Mantoux test due to the cross-reactivity of the vaccine with the tuberculosis test. Therefore, relying on the Mantoux test alone can lead to false-positive results in this population.
Option A) Mantoux test is incorrect because, as mentioned earlier, individuals who have received the BCG vaccine are likely to have a positive Mantoux test result even if they do not have a TB infection. This test may not accurately differentiate between a true TB infection and a response to the BCG vaccine.
Option B) Chest x-ray is incorrect as a standalone screening method because it can detect active TB disease but may not be sensitive enough to pick up latent TB infection, especially in individuals who have received the BCG vaccine.
Option C) Sputum culture is not the most appropriate screening method for latent TB infection in this scenario as it is more commonly used to diagnose active TB disease rather than latent infection.
Educationally, it is crucial to understand the limitations of the Mantoux test in individuals who have received the BCG vaccine and to consider alternative screening methods such as blood tests (e.g., interferon-gamma release assays) to accurately assess TB infection status in this population. This knowledge is essential for healthcare professionals involved in TB screening and management to ensure proper diagnosis and treatment decisions.
Option A) Mantoux test is incorrect because, as mentioned earlier, individuals who have received the BCG vaccine are likely to have a positive Mantoux test result even if they do not have a TB infection. This test may not accurately differentiate between a true TB infection and a response to the BCG vaccine.
Option B) Chest x-ray is incorrect as a standalone screening method because it can detect active TB disease but may not be sensitive enough to pick up latent TB infection, especially in individuals who have received the BCG vaccine.
Option C) Sputum culture is not the most appropriate screening method for latent TB infection in this scenario as it is more commonly used to diagnose active TB disease rather than latent infection.
Educationally, it is crucial to understand the limitations of the Mantoux test in individuals who have received the BCG vaccine and to consider alternative screening methods such as blood tests (e.g., interferon-gamma release assays) to accurately assess TB infection status in this population. This knowledge is essential for healthcare professionals involved in TB screening and management to ensure proper diagnosis and treatment decisions.